Eszter Schäfer

544 total citations
14 papers, 158 citations indexed

About

Eszter Schäfer is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Eszter Schäfer has authored 14 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in Eszter Schäfer's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Eszter Schäfer is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Eszter Schäfer collaborates with scholars based in Hungary, Canada and Croatia. Eszter Schäfer's co-authors include Klaudia Farkas, Anita Illés, Gabriella Horváth, Andrea Tamás, Dóra Reglődi, Balázs Opper, Tamás Molnár, Lóránt Gönczi, Péter L. Lakatos and Ákos Iliás and has published in prestigious journals such as Gastroenterology, Clinical Gastroenterology and Hepatology and Frontiers in Endocrinology.

In The Last Decade

Eszter Schäfer

14 papers receiving 157 citations

Peers

Countries citing papers authored by Eszter Schäfer

Since Specialization

Citations

This map shows the geographic impact of Eszter Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eszter Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eszter Schäfer more than expected).

Fields of papers citing papers by Eszter Schäfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eszter Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eszter Schäfer. The network helps show where Eszter Schäfer may publish in the future.

Co-authorship network of co-authors of Eszter Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Eszter Schäfer. A scholar is included among the top collaborators of Eszter Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eszter Schäfer. Eszter Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab 2024 ·Biomedicines ·(unknown), Nelli Farkas, (unknown), Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Tamás Molnár, Eszter Schäfer, T Szamosi, Á Salamon, Áron Vincze, Patrícia Sarlós	4
2	Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study 2022 ·Digestive and Liver Disease ·(unknown), Lóránt Gönczi, (unknown), (unknown), (unknown), Klaudia Farkas, Tamás Molnár, Pál Miheller, Petra A. Golovics, Eszter Schäfer, Tamás Szamosi, Ákos Iliás, Péter L. Lakatos	10
3	Hungarian Linguistic, Cross-Cultural, and Age Adaptation of the Patient Satisfaction with Health Care in Inflammatory Bowel Disease Questionnaire (CACHE) and the Medication Adherence Report Scale (MARS) 2022 ·Children ·(unknown), Alex Váradi, Nelli Farkas, Adrienn Erös, Andrea Párniczky, Eszter Schäfer, (unknown), (unknown), Péter Hegyi, Patrícia Sarlós	2
4	Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study 2022 ·Therapeutic Advances in Gastroenterology ·(unknown), Mária Matúz, (unknown), Pál Miheller, T Szamosi, Eszter Schäfer, Patrícia Sarlós, Ákos Iliás, (unknown), Mariann Rutka, Anita Bálint, Ágnes Milassin, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas	9
5	Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective 2021 ·BMC Proceedings ·Laimas Virginijus Jonaitis, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, (unknown), (unknown), Zoya Spassova, (unknown), (unknown), (unknown), (unknown), (unknown), Eszter Schäfer, Viktor Uršič, (unknown), David Drobne	42
6	Heveny gastrointestinalis vérzések ellátása. Multidiszciplináris útmutató javaslat 2020 ·Orvosi Hetilap ·T Gyökeres, Eszter Schäfer, Attila Szepes, Zsuzsanna Vitális, Mária Papp, I Altorjay, László Czakó, Áron Vincze, Attila Bursics, Péter Kanizsai, (unknown)	2
7	Patient and general population values for luminal and perianal fistulising Crohn’s disease health states 2019 ·The European Journal of Health Economics ·Fanni Rencz, Peep F. M. Stalmeier, Márta Péntek, Valentin Brodszky, (unknown), Lóránt Gönczi, Károly Palatka, László Herszényi, Eszter Schäfer, János Banai, Mariann Rutka, László Gulàcsi, Péter L. Lakatos	6
8	Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade 2019 ·Clinical Gastroenterology and Hepatology ·Ákos Iliás, (unknown), Lóránt Gönczi, Zsuzsanna Kürti, Petra A. Golovics, Klaudia Farkas, Eszter Schäfer, Zoltán Szepes, Balázs Szalay, Áron Vincze, Tamás Szamosi, Tamás Molnár, Péter L. Lakatos	29
9	Mo1892 – Non-Medical Reverse Switch Between the Originator Infliximab and Its Biosimilar in Patients with Inflammatory Bowel Disease: Clinical Outcomes and Therapeutic Drug Monitoring 2019 ·Gastroenterology ·Lóránt Gönczi, Ákos Iliás, (unknown), Zsuzsanna Kürti, Petra A. Golovics, Klaudia Farkas, Eszter Schäfer, Zoltán Szepes, Balázs Szalay, Áron Vincze, T Szamosi, Tamás Molnár, Péter L. Lakatos	1
10	Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach 2018 ·Frontiers in Endocrinology ·Dóra Reglődi, Anita Illés, Balázs Opper, Eszter Schäfer, Andrea Tamás, Gabriella Horváth	27
11	Mo1843 - Non-Medical Mandatory Reversed and Back and Forth Switch Between Infliximab and its Biosimilar: Early Clinical Outcomes 2018 ·Gastroenterology ·Ákos Iliás, (unknown), Lóránt Gönczi, Zsuzsanna Kürti, Petra A. Golovics, T Szamosi, Eszter Schäfer, Klaudia Farkas, Zoltán Szepes, Tamás Molnár, Áron Vincze, Péter L. Lakatos	1
12	S1143 Azathioprine/Biological Therapy Does Prevent Surgery But Not Reoperation in Smokers with Crohn's Disease 2009 ·Gastroenterology ·Péter L. Lakatos, T Szamosi, (unknown), J. Papp, Eszter Schäfer, Gyula Dávid, Tünde Pandúr, Zsuzsanna Erdélyi, János Banai	1
13	Functional Evaluation of Multidrug Resistance Transporter Activity in Surgical Samples of Solid Tumors 2007 ·Assay and Drug Development Technologies ·Richárd Schwab, Tamás Micsík, (unknown), Eszter Schäfer, (unknown), Tibor Tihanyi, Péter Kupcsulik, (unknown), (unknown), I Besznyák, Attila Zaránd, Rudolf Mihalik, Balázs Sarkadi, Gÿorgý Kéri, Ákos Pap, F Jakab, László Kopper, István Peták	5
14	Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR Inhibitors 2005 ·Journal of Receptors and Signal Transduction ·(unknown), Eszter Schäfer, (unknown), (unknown), László Őrfi, István Peták, Ákos Pap, (unknown), Gÿorgý Kéri, Richárd Schwab	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact